The Airflow Study

We are conducting a healthy volunteer study to investigate the interaction between an investigational drug and an already approved medication, both used to slow the progression of idiopathic pulmonary fibrosis (IPF).

This study aims to improve the quality of life for patients by managing the symptoms and progression of these serious lung conditions. The investigational drug has the potential to be more effective, better tolerated, and safer for treating IPF. It could provide the same benefits at lower doses without losing its effectiveness.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time